Spin off

Imagen subrayado titulo
  • Aligen Therapeutics.
    Company focused on cardiovascular diseases

    Aligen Therapeutics is a spin out of the Center for Applied Medical Research (CIMA), of the University of Navarra, Spain. Aligen holds licenses of CIMA’s patents and know-how on cardiovascular research. The aim of the establishment, fully owned by CIMA, is to be a business-friendly interface with investors, while keeping a privileged access to CIMA’s researchers and facilities.

    TEASER: "New antihemorrhagic agents: a novel antifibrinolytic strategy"

    Update date: September 2018


    Contact:
    Business Development Unit: bdcima@unav.es

  • Epical Biosciences.
    Company focused on cancer research

    Epical Biosciences is a spin out of the Center for Applied Medical Research (CIMA), of the University of Navarra, Spain. Epical Biosciences holds licenses of CIMA’s patents and know-how on cancer research. The aim of the establishment, fully owned by CIMA, is to be a business-friendly interface with investors, while keeping a privileged access to CIMA’s researchers and facilities.

    TEASER: "New epigenetic agents: therapeutic approach in cancer"

    Update date: September 2018


    Contact:
    Business Development Unit: bdcima@unav.es

Business development

Contact:
Centro de Investigación Médica Aplicada (CIMA)
Avenida Pío XII, 55
31008 Pamplona
España

+34 948 194 700
bdcima@unav.es

Notice

The University of Navarra uses cookies to improve its services, generate statistical data and analyze the browsing habits of visitors to its website. This information may be shared with third parties as detailed in the Cookies Policy Statement. By clicking “I agree” or continuing to browse, you consent to the use of these cookies, while reserving the right to reverse the decision at will.

Agree